Silence Therapeutics plc (SLN)

Silence Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	121.33	68.79	66.05	73.54	27.45
Short-Term Investments	26	-	19.67	-	10
Cash & Short-Term Investments	147.33	68.79	85.72	73.54	37.45
Cash Growth	114.18%	-19.75%	16.57%	96.37%	11.73%
Accounts Receivable	0.97	0.29	1.1	0.33	29.31
Other Receivables	25.94	23.69	19.79	8.16	4.21
Receivables	26.91	23.98	20.9	8.49	33.52
Prepaid Expenses	13.12	10.39	9.88	4.31	3.94
Other Current Assets	-	-	-	-	1.49
Total Current Assets	187.37	103.15	116.5	86.33	76.4
Property, Plant & Equipment	1.98	2.31	2.65	1.94	1.13
Long-Term Investments	-	-	0.34	0.3	0.3
Goodwill	9.39	9.98	9.65	7.59	8.13
Other Intangible Assets	0.31	0.36	0.39	0.02	0.02
Other Long-Term Assets	3.59	3.65	-	-	-
Total Assets	202.64	119.45	129.53	96.19	85.97
Accounts Payable	3.7	3.35	3.84	4.07	2.29
Accrued Expenses	12.05	11.72	10.67	6.53	5.91
Current Portion of Leases	0.12	0.23	0.54	0.14	0.34
Current Income Taxes Payable	0.65	0.47	0.71	0.19	-
Current Unearned Revenue	0.31	6.57	10.68	4.25	17.04
Total Current Liabilities	16.82	22.34	26.44	15.17	25.58
Long-Term Leases	-	0.12	-	-	-
Long-Term Unearned Revenue	51.79	75	76.49	72.5	51.34
Total Liabilities	68.61	97.46	102.93	87.67	76.91
Common Stock	10.29	8.85	6.49	4.49	4.17
Additional Paid-In Capital	609.56	455.77	273.11	184.33	153.73
Retained Earnings	-485.83	-442.62	-317.2	-222.97	-184.22
Comprehensive Income & Other	-	-	64.19	42.67	35.38
Shareholders' Equity	134.02	21.99	26.59	8.53	9.06
Total Liabilities & Equity	202.64	119.45	129.53	96.19	85.97
Total Debt	0.12	0.35	0.54	0.14	0.34
Net Cash (Debt)	147.22	68.44	85.18	73.4	37.11
Net Cash Growth	115.09%	-19.65%	16.05%	97.80%	11.67%
Net Cash Per Share	3.18	1.85	2.65	2.48	1.36
Filing Date Shares Outstanding	47.22	46.5	35.95	29.93	27.77
Total Common Shares Outstanding	47.22	39.62	35.94	29.93	27.77
Working Capital	170.54	80.82	90.06	71.17	50.82
Book Value Per Share	2.84	0.56	0.74	0.28	0.33
Tangible Book Value	124.32	11.65	16.56	0.91	0.92
Tangible Book Value Per Share	2.63	0.29	0.46	0.03	0.03
Machinery	6.34	6.44	6.01	5.11	4.07

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q